At the news
? NEUTRALIMPACT 2/10 8-K filed May 13, 2026 at 07:30 ET
Palvella Therapeutics received approval from Nasdaq to transfer its common stock listing from the Nasdaq Capital Market to the Nasdaq Global Market, effective May 13, 2026. The ticker symbol PVLA remains unchanged. This is an administrative listing upgrade with no financial impact.
- Nasdaq approved transfer from Capital Market to Global Market on May 11, 2026
- Transfer effective at open of business on May 13, 2026
- Ticker symbol PVLA unchanged
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access